Project Stealth

Donate to Project Stealth

Help us in this cutting-edge research effort in the fight against cancer.

Give to Project Stealth

Our Researchers

Chief of Pediatric Surgery:
Dan Saltzman, M.D., Ph.D. 

Director of Pediatric Surgical Research Lab:
Lance Augustin, Ph.D. 

Project Stealth is re-engineering cancer therapy.

Research being conducted by Dr. Daniel A. Saltzman at the University of Minnesota is focusing on a new and potentially breakthrough therapy in the fight against cancer. This therapy uses altered or "attenuated" salmonella bacteria to deliver anti-cancer drugs directly to tumor cells. The early phases of this research have been highly successful, but before this therapy can be used to treat cancer patients, more work and research need to be done.

Visit for more information.

Recent News 

Project Stealth featured in Minnesota Medicine article

Dr. Saltzman describes his creative methods to securing funding for an innovative treatment to cancer.  Through crowdsourcing, Dr. Saltzman has raised $175,000 of the $500,000 needed to complete the research required to file an Investigational New Drug application with the Food and Drug Administration

Read the full article here

Project Stealth featured in TEDx Talk at Carlton College

Dr. Saltzman describes the challenges of treating cancer and a novel solution that he hopes can lead to a cure.

Dr. Saltzman featured in Project Stealth articles

'So Saltzman has teamed up with an entrepreneur in the television industry and Twin Cities advertising and public relations professionals to make an unusual direct appeal to the public. In the process, he’s helping to bring so-called crowdsourcing to the field of medical research.'


'Dr. Daniel Saltzman first heard of using salmonella to combat disease while working in a lab as a graduate student. Twenty years later, the chief of pediatric surgery at the University of Minnesota Masonic Children's Hospital has made a remarkable finding: because salmonella, food-borne bacteria, is naturally drawn to cancers, it can be a potent weapon against the deadly disease. When he is not performing surgeries or administrative duties, Saltzman is working to move salmonella to the marketplace as an effective, cheaper and less toxic therapy than what is currently available.'

Read more at  

More information